On December 9, Hong Kong stocks bounced back in early trading. As of press time, the Hang Seng Index rose 1.11%, the Hang Seng Technology Index rose 2.13%; Skyworth Group rose more than 18%; Longyuan Power rose 8.18%; Alibaba Health rose nearly 5%, Tengsheng Bo Pharmaceutical rose 4.32%; Alibaba rose 2.07% ; Kuaishou rose 3.27%.
On December 9, Hong Kong stocks bounced back in early trading.
At the beginning of the market, the Hang Seng Index and the Hang Seng Technology Index opened slightly higher, and then went higher all the way. As of press time, the Hang Seng Index rose 1.11%, and the Hang Seng Technology Index rose 2.13%.
The LED concept leads the HSI. As of press time, Skyworth Group has risen by more than 18%; Weizhi Holdings has risen by more than 5%.
The wind power sector performed well in early trading. As of press time, Longyuan Power rose 8.18%; Xintian Green Energy and Jingneng Clean Energy rose more than 4%.
The education sector performed well. As of press time, Hope Education has risen by more than 9%, New Oriental has risen by more than 8%, and New Oriental Online has risen by more than 4%.
The medical sector performed well. As of press time, Qiming Medical has risen by more than 7%; Ali Health has risen by nearly 5%; Tengshengbo Pharmaceutical has risen by 4.32%. At the opening of the market, the stock once rose by more than 9%. On the news, the State Food and Drug Administration has approved the company for The neutralizing antibody combination therapy for the treatment of new coronary pneumonia is the first domestically approved new crown specific drug with independent intellectual property rights.
In addition, the Internet sector has also gained momentum. As of press time, Alibaba is up 2.07%; Tencent is up 0.99%; Meituan is up 1.63%; Kuaishou is up 3.27%.
Risk warning and exemption clause
Market risk, the investment need to be cautious. This article does not constitute personal investment advice, nor does it take into account the specific investment objectives, financial situation or needs of individual users. Users should consider whether any opinions, opinions, or conclusions in this article are consistent with their specific conditions. Invest accordingly at your own risk.